Nuvation Bio Inc.
NUVB · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $13,120 | $4,833 | $3,084 | $5,711 |
| % Growth | 171.5% | 56.7% | -46% | – |
| Cost of Goods Sold | $3,349 | $2,576 | $2,094 | $4,216 |
| Gross Profit | $9,771 | $2,257 | $990 | $1,495 |
| % Margin | 74.5% | 46.7% | 32.1% | 26.2% |
| R&D Expenses | $28,846 | $27,362 | $24,601 | $29,299 |
| G&A Expenses | $36,859 | $0 | $0 | $0 |
| SG&A Expenses | $37,359 | $38,484 | $35,393 | $26,138 |
| Sales & Mktg Exp. | $500 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $66,205 | $65,846 | $59,994 | $55,437 |
| Operating Income | -$56,434 | -$63,589 | -$59,004 | -$53,942 |
| % Margin | -430.1% | -1,315.7% | -1,913.2% | -944.5% |
| Other Income/Exp. Net | $642 | $4,582 | $5,768 | $4,497 |
| Pre-Tax Income | -$55,792 | -$59,007 | -$53,236 | -$49,445 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$55,792 | -$59,007 | -$53,236 | -$49,445 |
| % Margin | -425.2% | -1,220.9% | -1,726.2% | -865.8% |
| EPS | -0.16 | -0.17 | -0.16 | -0.15 |
| % Growth | 5.9% | -6.3% | -6.7% | – |
| EPS Diluted | -0.16 | -0.17 | -0.16 | -0.15 |
| Weighted Avg Shares Out | 342,394 | 340,746 | 338,612 | 336,934 |
| Weighted Avg Shares Out Dil | 342,393 | 340,746 | 338,612 | 336,934 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $4,780 | $5,321 | $6,062 |
| Interest Expense | $501 | $421 | $54 | $89 |
| Depreciation & Amortization | $534 | $356 | $310 | $219 |
| EBITDA | -$54,757 | -$58,230 | -$52,872 | -$49,137 |
| % Margin | -417.4% | -1,204.8% | -1,714.4% | -860.4% |